Lowe-Krentz L - Search Results

1

Identification of 1- and 3-methylhistidine as biomarkers of skeletal muscle toxicity by nuclear magnetic resonance-based metabolic profiling.

Aranibar N, Vassallo JD, Rathmacher J, Stryker S, Zhang Y, Dai J, Janovitz EB, Robertson D, Reily M, Lowe-Krentz L, Lehman-McKeeman L. Aranibar N, et al. Anal Biochem. 2011 Mar 1;410(1):84-91. doi: 10.1016/j.ab.2010.11.023. Epub 2010 Nov 19. Anal Biochem. 2011. PMID: 21094120

2

Biomarkers of drug-induced skeletal muscle injury in the rat: troponin I and myoglobin.

Vassallo JD, Janovitz EB, Wescott DM, Chadwick C, Lowe-Krentz LJ, Lehman-McKeeman LD. Vassallo JD, et al. Toxicol Sci. 2009 Oct;111(2):402-12. doi: 10.1093/toxsci/kfp166. Epub 2009 Jul 23. Toxicol Sci. 2009. PMID: 19628585

3

Heparin treatment of vascular smooth muscle cells results in the synthesis of the dual-specificity phosphatase MKP-1.

Blaukovitch CI, Pugh R, Gilotti AC, Kanyi D, Lowe-Krentz LJ. Blaukovitch CI, et al. J Cell Biochem. 2010 May 15;110(2):382-91. doi: 10.1002/jcb.22543. J Cell Biochem. 2010. PMID: 20235148 Free PMC article.

4

Antibodies against a putative heparin receptor slow cell proliferation and decrease MAPK activation in vascular smooth muscle cells.

Savage JM, Gilotti AC, Granzow CA, Molina F, Lowe-Krentz LJ. Savage JM, et al. J Cell Physiol. 2001 Jun;187(3):283-93. doi: 10.1002/jcp.1076. J Cell Physiol. 2001. PMID: 11319752

5

Heparin responses in vascular smooth muscle cells involve cGMP-dependent protein kinase (PKG).

Gilotti AC, Nimlamool W, Pugh R, Slee JB, Barthol TC, Miller EA, Lowe-Krentz LJ. Gilotti AC, et al. Among authors: lowe krentz lj. J Cell Physiol. 2014 Dec;229(12):2142-52. doi: 10.1002/jcp.24677. J Cell Physiol. 2014. PMID: 24911927 Free PMC article.

6

Heparin Decreases in Tumor Necrosis Factor α (TNFα)-induced Endothelial Stress Responses Require Transmembrane Protein 184A and Induction of Dual Specificity Phosphatase 1.

Farwell SL, Kanyi D, Hamel M, Slee JB, Miller EA, Cipolle MD, Lowe-Krentz LJ. Farwell SL, et al. Among authors: lowe krentz lj. J Biol Chem. 2016 Mar 4;291(10):5342-54. doi: 10.1074/jbc.M115.681288. Epub 2016 Jan 14. J Biol Chem. 2016. PMID: 26769965 Free PMC article.

7

Transmembrane Protein 184A Is a Receptor Required for Vascular Smooth Muscle Cell Responses to Heparin.

Pugh RJ, Slee JB, Farwell SL, Li Y, Barthol T, Patton WA, Lowe-Krentz LJ. Pugh RJ, et al. Among authors: lowe krentz lj. J Biol Chem. 2016 Mar 4;291(10):5326-41. doi: 10.1074/jbc.M115.681122. Epub 2016 Jan 14. J Biol Chem. 2016. PMID: 26769966 Free PMC article.

8

Active stress kinases in proliferating endothelial cells associated with cytoskeletal structures.

Hamel M, Kanyi D, Cipolle MD, Lowe-Krentz L. Hamel M, et al. Endothelium. 2006 May-Jun;13(3):157-70. doi: 10.1080/10623320600760191. Endothelium. 2006. PMID: 16840172

9

Endothelial nitric oxide synthase activation is required for heparin receptor effects on vascular smooth muscle cells.

Li Y, Talotta-Altenburg LM, Silimperi KA, Ciabattoni GO, Lowe-Krentz LJ. Li Y, et al. Among authors: lowe krentz lj. Am J Physiol Cell Physiol. 2020 Mar 1;318(3):C463-C475. doi: 10.1152/ajpcell.00284.2018. Epub 2019 Dec 31. Am J Physiol Cell Physiol. 2020. PMID: 31891520 Free PMC article.

10

Heparin releasable and nonreleasable forms of heparan sulfate proteoglycan are found on the surfaces of cultured porcine aortic endothelial cells.

Lowe-Krentz LJ, Thompson K, Patton WA 2nd. Lowe-Krentz LJ, et al. Mol Cell Biochem. 1992 Jan 15;109(1):51-60. doi: 10.1007/BF00230873. Mol Cell Biochem. 1992. PMID: 1614420

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters